These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24018533)

  • 1. Optimal conditions required for influenza A infection-enhanced cross-priming of CD8⁺ T cells specific to cell-associated antigens.
    Wei J; Waithman J; Xiao K; Oveissi S; Chen W
    Immunol Cell Biol; 2013 Oct; 91(9):576-82. PubMed ID: 24018533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.
    Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W
    J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response.
    Hemann EA; Sjaastad LE; Langlois RA; Legge KL
    J Virol; 2015 Dec; 90(6):2830-7. PubMed ID: 26719269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.
    Uhl M; Kepp O; Jusforgues-Saklani H; Vicencio JM; Kroemer G; Albert ML
    Cell Death Differ; 2009 Jul; 16(7):991-1005. PubMed ID: 19229247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming.
    Barbet G; Nair-Gupta P; Schotsaert M; Yeung ST; Moretti J; Seyffer F; Metreveli G; Gardner T; Choi A; Tortorella D; Tampé R; Khanna KM; García-Sastre A; Blander JM
    Nat Immunol; 2021 Apr; 22(4):497-509. PubMed ID: 33790474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide].
    Tan XH; Liu C; Wan YH
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):658-61. PubMed ID: 17274369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
    Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
    Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells.
    Smed-Sörensen A; Chalouni C; Chatterjee B; Cohn L; Blattmann P; Nakamura N; Delamarre L; Mellman I
    PLoS Pathog; 2012; 8(3):e1002572. PubMed ID: 22412374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.
    Chen W; Masterman KA; Basta S; Haeryfar SM; Dimopoulos N; Knowles B; Bennink JR; Yewdell JW
    Eur J Immunol; 2004 Jan; 34(1):194-9. PubMed ID: 14971045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.
    Palucka AK; Ueno H; Connolly J; Kerneis-Norvell F; Blanck JP; Johnston DA; Fay J; Banchereau J
    J Immunother; 2006; 29(5):545-57. PubMed ID: 16971810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definition of key variables for the induction of optimal NY-ESO-1-specific T cells in HLA transgene mice.
    Johannsen A; Genolet R; Legler DF; Luther SA; Luescher IF
    J Immunol; 2010 Sep; 185(6):3445-55. PubMed ID: 20733200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential killers exposed: tracking endogenous influenza-specific CD8
    Keating R; Morris MY; Yue W; Reynolds CE; Harris TL; Brown SA; Doherty PC; Thomas PG; McGargill MA
    Immunol Cell Biol; 2018 Nov; 96(10):1104-1119. PubMed ID: 29972699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen bias in T cell cross-priming.
    Wolkers MC; Brouwenstijn N; Bakker AH; Toebes M; Schumacher TN
    Science; 2004 May; 304(5675):1314-7. PubMed ID: 15166378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity.
    Kim JH; Chen J; Majumder N; Lin H; Falo LD; You Z
    Gene Ther; 2005 Oct; 12(20):1517-25. PubMed ID: 16052205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannan-modified adenovirus as a vaccine to induce antitumor immunity.
    Ding ZY; Wu Y; Luo Y; Su JM; Li Q; Zhang XW; Liu JY; He QM; Yang L; Tian L; Zhao X; Deng HX; Wen YJ; Li J; Kang B; Wei YQ
    Gene Ther; 2007 Apr; 14(8):657-63. PubMed ID: 17287861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⁺ T cells.
    Liang X; Fu C; Cui W; Ober-Blöbaum JL; Zahner SP; Shrikant PA; Clausen BE; Flavell RA; Mellman I; Jiang A
    J Leukoc Biol; 2014 Jan; 95(1):179-90. PubMed ID: 24023259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo.
    Dolfi DV; Duttagupta PA; Boesteanu AC; Mueller YM; Oliai CH; Borowski AB; Katsikis PD
    J Immunol; 2011 Apr; 186(8):4599-608. PubMed ID: 21389258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.
    Preynat-Seauve O; Contassot E; Schuler P; French LE; Huard B
    Melanoma Res; 2007 Jun; 17(3):169-76. PubMed ID: 17505262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helping themselves: optimal virus-specific CD4 T cell responses require help via CD4 T cell licensing of dendritic cells.
    Olson MR; Seah SG; Cullen J; Greyer M; Edenborough K; Doherty PC; Bedoui S; Lew AM; Turner SJ
    J Immunol; 2014 Dec; 193(11):5420-33. PubMed ID: 25339661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.